粪便初级胆汁酸分析可检测慢性功能性腹泻患者粪便重量增加和结肠传输加快
本研究回顾性分析64例腹泻型肠易激综合征(IBS-D)、30例便秘型肠易激综合征患者及30名健康对照,评估粪便初级胆汁酸百分比与48小时粪便总胆汁酸对粪便重量增加(>400g/48h)和结肠传输加快(几何中心>3.34)的识别能力,并在938例慢性腹泻患者中估计48小时粪便胆汁酸升高的患病率。
要点
- 粪便初级胆汁酸百分比>10%识别粪便重量增加的灵敏度49%、特异度91%,识别结肠传输加快的灵敏度48%、特异度87%。
- 48小时粪便总胆汁酸联合初级胆汁酸百分比识别粪便重量增加的AUROC为0.86。
- 慢性腹泻患者中45.6%粪便初级胆汁酸>10%,27%粪便总胆汁酸升高(>2337 μmol/48小时)。
核心结论
- 在IBS-D患者的回顾性分析中,粪便初级胆汁酸百分比可作为粪便总胆汁酸的替代指标,用于识别胆汁酸腹泻或慢性腹泻患者。
研究设计与样本
- 回顾性研究,纳入64例IBS-D患者、30例IBS-便秘患者和30名健康对照。
- 收集48小时粪便重量、24小时结肠闪烁显像传输(几何中心1至5分)及粪便不同胆汁酸百分比数据。
- 在938例慢性腹泻患者中估计48小时粪便胆汁酸升高的患病率。
主要发现
- 48小时粪便总胆汁酸单独或联合粪便初级胆汁酸百分比识别粪便重量增加(>400g/48h)的AUROC为0.86。
- 粪便初级胆汁酸百分比单独识别粪便重量增加的AUROC为0.73。
- 48小时粪便总胆汁酸单独识别结肠传输加快(>3.34)的AUROC为0.65,初级胆汁酸百分比单独为0.69,两者联合为0.70。
- 血清C4识别结肠传输加快的AUROC为0.60。
- 慢性腹泻患者中45.6%粪便初级胆汁酸>10%,27%粪便总胆汁酸升高(>2337 μmol/48小时)。
关键数值与推荐
- 粪便初级胆汁酸>10%识别粪便重量增加的灵敏度49%、特异度91%。
- 粪便初级胆汁酸>10%识别结肠传输加快的灵敏度48%、特异度87%。
- 粪便重量增加定义为>400g/48小时,结肠传输加快定义为几何中心>3.34。
- 粪便总胆汁酸升高定义为>2337 μmol/48小时。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with bile acid diarrhea (BAD) are identified based on increased levels of BAs in fecal samples collected over a 48-hr period while on a 100-gram fat diet (48-hr BA), retention of 75Se-labeled homocholic acid taurine, or serum levels of C4 or FGF19. BAD increases fecal weight and colonic transit. We investigated whether results of tests for BAD associate with increased fecal weight and more rapid colonic transit over a 24- or 48-hr period in patients with irritable bowel syndrome with diarrhea (IBS-D). We also estimated the prevalence of increased 48-hr fecal BAs in patients with chronic diarrhea. METHODS: We performed a retrospective study of 64 patients with IBS-D, 30 patients with IBS-constipation, 30 healthy volunteers (controls). We collected data on fecal weights (measured over a 48-hr period), colonic transit over a 24-hr period (measured by scintigraphy), and percentages of different BAs in stool samples. Colonic transit was measured as the geometric center (weighted average) of colonic counts on a scale of 1 (100% in ascending colon) to 5 (100% in stool). We performed area under the curve (AUC) analyses to assess the association between result of serum and stool tests and high fecal weight (>400g/48 hrs) or rapid colonic transit (>3.34, corresponding to isotope geometric center in sigmoid colon). We estimated the prevalence of increased 48-hr fecal BAs among 938 patients with chronic diarrhea. RESULTS: Total fecal 48-hr BA alone, or in combination with percentage of primary fecal BAs, identified patients with increased fecal weight with an AUROC of 0.86. Percentage of primary fecal BA alone identified patients with increased fecal weight with an AUROC of 0.73. Total fecal 48-hr BA alone identified patients with increased colonic transit with an AUROC of 0.65 and percentage of primary fecal BA alone identified patients with increased colonic transit with an AUROC of 0.69; combined data on these features identified patients with increased colonic transit with an AUROC of 0.70. Serum level of C4 identified patients with increased colonic transit with an AUROC of 0.60. Primary BAs >10% identified patients with increased fecal weight (sensitivity 49% and specificity 91%) and rapid colonic transit (sensitivity 48% and specificity 87%). Among the patients with chronic diarrhea, 45.6% had fecal primary BAs >10% and 27% had increased total fecal BAs (>2337 μmol/48 hrs). CONCLUSIONS: In a retrospective analysis of patients with IBS-D, we found percentage of primary BAs in fecal samples to provide an alternative to total fecal BAs in identification of patients with BAD or chronic diarrhea.
引用
- Vijayvargiya P, Camilleri M, Chedid V, et al. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea. Clin Gastroenterol Hepatol. 2018. PMID: 29902647. doi:10.1016/j.cgh.2018.05.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。